Sweeney M, Carpenter L, de Souza S, Caton E, Galloway J, Cope A
Rheumatol Int. 2025; 45(2):31.
PMID: 39821463
PMC: 11741988.
DOI: 10.1007/s00296-024-05761-8.
Lee H, Lee S, Lim H, Kim H, Kim R, Cheon Y
Clin Pract. 2024; 14(6):2475-2483.
PMID: 39585021
PMC: 11587020.
DOI: 10.3390/clinpract14060193.
van der Veer S, Griffiths-Jones D, Parkes M, Druce K, Amlani-Hatcher P, Armitage C
Trials. 2024; 25(1):683.
PMID: 39407290
PMC: 11481815.
DOI: 10.1186/s13063-024-08497-9.
Brady S, Mott A, Carlisle K, Abhishek A, Adamson J, Coates L
BMJ Open. 2024; 14(6):e084997.
PMID: 38910007
PMC: 11328622.
DOI: 10.1136/bmjopen-2024-084997.
Tang Y, Varavko Y, Aringazina R, Menshikova I
Asian J Urol. 2024; 11(2):304-310.
PMID: 38680581
PMC: 11053339.
DOI: 10.1016/j.ajur.2022.06.005.
Rheumatoid arthritis epidemiology: a nationwide study in Poland.
Krajewska-Wlodarczyk M, Szelag M, Batko B, Zuber Z, Orleanski M, Podwojcic K
Rheumatol Int. 2024; 44(6):1155-1163.
PMID: 38678142
PMC: 11108940.
DOI: 10.1007/s00296-024-05591-8.
Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases.
Fuller A, Hancox J, Williams H, Card T, Taal M, Aithal G
Rheumatology (Oxford). 2024; 64(3):969-975.
PMID: 38483276
PMC: 11879332.
DOI: 10.1093/rheumatology/keae175.
Arthritis prevalence is associated with metabolic syndrome risk factors but not with physical activity in middle-aged and older patients - a cross-sectional study.
Qiu F, Li J, Gan L, Legerlotz K
BMC Geriatr. 2024; 24(1):242.
PMID: 38459429
PMC: 10924363.
DOI: 10.1186/s12877-024-04859-9.
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation.
Abhishek A, Grainge M, Card T, Williams H, Taal M, Aithal G
RMD Open. 2024; 10(1).
PMID: 38453215
PMC: 10921482.
DOI: 10.1136/rmdopen-2023-003980.
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review.
Leaviss J, Carroll C, Essat M, Van der Windt D, Grainge M, Card T
RMD Open. 2024; 10(1).
PMID: 38199851
PMC: 10806492.
DOI: 10.1136/rmdopen-2023-003588.
Rheumatoid Arthritis Has Won the Battle but Not the War: How Many Joints Will We Save Tomorrow?.
Oberemok V, Andreeva O, Laikova K, Alieva E, Temirova Z
Medicina (Kaunas). 2023; 59(10).
PMID: 37893571
PMC: 10608469.
DOI: 10.3390/medicina59101853.
Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation.
Nakafero G, Card T, Grainge M, Williams H, Taal M, Aithal G
EClinicalMedicine. 2023; 64:102213.
PMID: 37745026
PMC: 10514402.
DOI: 10.1016/j.eclinm.2023.102213.
Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years.
Ajeganova S, Andersson M, Forslind K, Gjertsson I, Nyhall-Wahlin B, Svensson B
BMC Rheumatol. 2023; 7(1):23.
PMID: 37550762
PMC: 10405460.
DOI: 10.1186/s41927-023-00347-6.
Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021.
Huang Y, Jenkins D, Yimer B, Benitez-Aurioles J, Peek N, Lunt M
Rheumatology (Oxford). 2023; 63(4):1093-1103.
PMID: 37432340
PMC: 10986805.
DOI: 10.1093/rheumatology/kead346.
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.
Nakafero G, Grainge M, Williams H, Card T, Taal M, Aithal G
BMJ. 2023; 381:e074678.
PMID: 37253479
PMC: 10227711.
DOI: 10.1136/bmj-2022-074678.
Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study.
McLoone P, Jani B, Siebert S, Morton F, Canning J, Macdonald S
J Multimorb Comorb. 2023; 13:26335565221148616.
PMID: 36798088
PMC: 9926377.
DOI: 10.1177/26335565221148616.
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY.
Russell M, Galloway J, Andrews C, Mackenna B, Goldacre B, Mehrkar A
Lancet Rheumatol. 2022; 4(12):e853-e863.
PMID: 36447940
PMC: 9691150.
DOI: 10.1016/S2665-9913(22)00305-8.
Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis.
Siempis T, Tsakiris C, Anastasia Z, Alexiou G, Voulgaris S, Argyropoulou M
Rheumatol Int. 2022; 43(2):195-208.
PMID: 36378323
PMC: 9898347.
DOI: 10.1007/s00296-022-05239-5.
Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003-2018.
West J, Stilwell P, Liu H, Ban L, Bythell M, Card T
Hemasphere. 2022; 6(11):e797.
PMID: 36340911
PMC: 9624441.
DOI: 10.1097/HS9.0000000000000797.
Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data.
Scott I, Whittle R, Bailey J, Twohig H, Hider S, Mallen C
Lancet Reg Health Eur. 2022; 23:100519.
PMID: 36246147
PMC: 9557034.
DOI: 10.1016/j.lanepe.2022.100519.